Does TRASTUZUMAB-ANNS Cause Disease progression? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Disease progression have been filed in association with TRASTUZUMAB-ANNS. This represents 1.5% of all adverse event reports for TRASTUZUMAB-ANNS.
21
Reports of Disease progression with TRASTUZUMAB-ANNS
1.5%
of all TRASTUZUMAB-ANNS reports
1
Deaths
2
Hospitalizations
How Dangerous Is Disease progression From TRASTUZUMAB-ANNS?
Of the 21 reports, 1 (4.8%) resulted in death, 2 (9.5%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-ANNS. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB-ANNS Cause?
Product storage error (346)
Circumstance or information capable of leading to medication error (257)
Off label use (104)
Intercepted product administration error (89)
Product dose omission issue (68)
Chills (58)
Dyspnoea (52)
Nausea (49)
Diarrhoea (48)
Rash (45)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TRASTUZUMAB-ANNS Alternatives Have Lower Disease progression Risk?
TRASTUZUMAB-ANNS vs TRASTUZUMAB DERUXTECAN
TRASTUZUMAB-ANNS vs TRASTUZUMAB-DKST
TRASTUZUMAB-ANNS vs TRASTUZUMAB-DTTB
TRASTUZUMAB-ANNS vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB-ANNS vs TRASTUZUMAB-PKRB